{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:10:06Z","timestamp":1795108206160,"version":"4.10.3"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["WND-POWR.03.02.00-00-I029\/16-01"],"award-info":[{"award-number":["WND-POWR.03.02.00-00-I029\/16-01"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The C\u2013C motif ligand 20 (CCL20) is a chemokine that specifically binds to the chemokine receptor 6 (CCR6) and the CCL20\/CCR6 axis has been implicated in the non-small lung cancer (NSCLC) development and progression. Its expression is regulated by mutual interactions of non-coding RNAs (ncRNAs). This goals of presented study was to evaluate the expression level of <jats:italic>CCR6\/CCL20<\/jats:italic> mRNA in NSCLC tissue comparative to selected ncRNAs: miR-150, linc00673. The expression level of the studied ncRNAs was also assessed in serum extracellular vesicles (EVs). Thirty patients (n\u2009=\u200930) were enrolled as the study cohort. Total RNA was isolated from tumor tissue, adjacent macroscopically unchanged tissue and serum EVs. The expression level of studied genes and ncRNAs were estimated based on the qPCR method. Higher expression level of <jats:italic>CCL20<\/jats:italic> mRNA but lower expression level of <jats:italic>CCR6<\/jats:italic> mRNA were observed in tumor in comparison to control tissue. Relative to the smoking status, higher <jats:italic>CCL20<\/jats:italic> (p\u2009&lt;\u20090.05) and <jats:italic>CCR6<\/jats:italic> mRNA (p\u2009&gt;\u20090.05) expression levels were observed in current smokers than in never smokers. In serum EVs the expression level of miR-150 has a negative correlation with AJCC tumor staging, whereas the expression level of linc00673 positively correlated (p\u2009&gt;\u20090.05). The lower expression level of miR-150 and higher expression level of linc00673 in serum EVs were observed in NSCLC patients with lymph nodes metastases (p\u2009&gt;\u20090.05). Regarding the histopathological type, significantly lower expression level of miR-150 and higher expression level of linc00673 were observed in the serum EVs of patients with AC compared to patient with SCC. Our findings revealed that smoking significantly changed the expression level of <jats:italic>CCL20<\/jats:italic> mRNA in NSCLC tissue. Changes in expression levels of miR-150 and linc00673 in the serum EVs of NSCLC patients in relation to presence of lymph node metastases and the stage of cancer development may serve as a non-invasive molecular biomarkers of tumor progression. Furthermore, expression levels of miR-150 and linc00673 may serve as non-intrusive diagnostic biomarkers differentiating adenocarcinoma from squamous cell carcinoma.<\/jats:p>","DOI":"10.1038\/s41598-023-36485-7","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T12:01:47Z","timestamp":1686744107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Panel of miR-150 and linc00673, regulators of CCR6\/CCL20 may serve as non-invasive diagnostic marker of non-small cell lung cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Kamila","family":"Baran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kordiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Jab\u0142o\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Brzezia\u0144ska-Lasota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"36485_CR1","unstructured":"Cancer today. http:\/\/gco.iarc.fr\/today\/home (Accessed 08 May 2022)."},{"key":"36485_CR2","unstructured":"Lung Cancer Survival Rates | 5-Year Survival Rates for Lung Cancer. https:\/\/www.cancer.org\/cancer\/lung-cancer\/detection-diagnosis-staging\/survival-rates.html#references (Accessed 03 August 2022)."},{"issue":"1","key":"36485_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5114\/wo.2021.103829","volume":"25","author":"KC Thandra","year":"2021","unstructured":"Thandra, K. C., Barsouk, A., Saginala, K., Aluru, J. S. & Barsouk, A. Epidemiology of lung cancer. Contemp. Oncol. (Pozn.) 25(1), 45\u201352. https:\/\/doi.org\/10.5114\/wo.2021.103829 (2021).","journal-title":"Contemp. Oncol. (Pozn.)"},{"issue":"4","key":"36485_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000324601","volume":"81","author":"IM Adcock","year":"2011","unstructured":"Adcock, I. M., Caramori, G. & Barnes, P. J. Chronic obstructive pulmonary disease and lung cancer: New molecular insights. Respiration 81(4), 265\u2013284. https:\/\/doi.org\/10.1159\/000324601 (2011).","journal-title":"Respiration"},{"issue":"1","key":"36485_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2015.04.005","volume":"363","author":"G-Z Wang","year":"2015","unstructured":"Wang, G.-Z. et al. Tobacco smoke induces production of chemokine CCL20 to promote lung cancer. Cancer Lett. 363(1), 60\u201370. https:\/\/doi.org\/10.1016\/j.canlet.2015.04.005 (2015).","journal-title":"Cancer Lett."},{"issue":"5","key":"36485_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/jcmm.12781","volume":"20","author":"B Wang","year":"2016","unstructured":"Wang, B. et al. Production of CCL20 from lung cancer cells induces the cell migration and proliferation through PI3K pathway. J. Cell. Mol. Med. 20(5), 920\u2013929. https:\/\/doi.org\/10.1111\/jcmm.12781 (2016).","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"36485_CR7","doi-asserted-by":"publisher","first-page":"e24856","DOI":"10.1371\/journal.pone.0024856","volume":"6","author":"S Kirshberg","year":"2011","unstructured":"Kirshberg, S. et al. Involvement of CCR6\/CCL20\/IL-17 axis in NSCLC disease progression. PLoS One 6(9), e24856. https:\/\/doi.org\/10.1371\/journal.pone.0024856 (2011).","journal-title":"PLoS One"},{"issue":"4","key":"36485_CR8","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1189\/jlb.0307133","volume":"82","author":"M Facco","year":"2007","unstructured":"Facco, M. et al. Expression and role of CCR6\/CCL20 chemokine axis in pulmonary sarcoidosis. J. Leukoc. Biol. 82(4), 946\u2013955. https:\/\/doi.org\/10.1189\/jlb.0307133 (2007).","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"36485_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1172\/JCI7548","volume":"105","author":"T Fushimi","year":"2000","unstructured":"Fushimi, T., Kojima, A., Moore, M. A. S. & Crystal, R. G. Macrophage inflammatory protein 3\u03b1 transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. J. Clin. Invest. 105(10), 1383\u20131393 (2000).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"36485_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13046-020-01622-x","volume":"39","author":"K Grillone","year":"2020","unstructured":"Grillone, K. et al. Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic \u201cdark matter\u201d. J. Exp. Clin. Cancer Res. 39(1), 117. https:\/\/doi.org\/10.1186\/s13046-020-01622-x (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"36485_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello, L., Guo, C.-J., Chen, L.-L. & Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol. 22(2), 96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"36485_CR12","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3390\/diagnostics12071610","volume":"12","author":"JA Wani","year":"2022","unstructured":"Wani, J. A. et al. MiRNAs in lung cancer: Diagnostic, prognostic, and therapeutic potential. Diagnostics (Basel) 12(7), 1610. https:\/\/doi.org\/10.3390\/diagnostics12071610 (2022).","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"36485_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/genes8010008","volume":"8","author":"M Kunz","year":"2016","unstructured":"Kunz, M. et al. Non-coding RNAs in lung cancer: Contribution of bioinformatics analysis to the development of non-invasive diagnostic tools. Genes (Basel) 8(1), 8. https:\/\/doi.org\/10.3390\/genes8010008 (2016).","journal-title":"Genes (Basel)"},{"issue":"5","key":"36485_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/thoraxjnl-2014-206193","volume":"70","author":"SF Vencken","year":"2015","unstructured":"Vencken, S. F., Greene, C. M. & McKiernan, P. J. Non-coding RNA as lung disease biomarkers. Thorax 70(5), 501\u2013503. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206193 (2015).","journal-title":"Thorax"},{"issue":"1","key":"36485_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep39001","volume":"6","author":"H Li","year":"2016","unstructured":"Li, H. et al. MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4. Sci. Rep. 6(1), 1. https:\/\/doi.org\/10.1038\/srep39001 (2016).","journal-title":"Sci. Rep."},{"issue":"15","key":"36485_CR16","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.febslet.2013.05.059","volume":"587","author":"N Zhang","year":"2013","unstructured":"Zhang, N., Wei, X. & Xu, L. miR-150 promotes the proliferation of lung cancer cells by targeting P53. FEBS Lett. 587(15), 2346\u20132351. https:\/\/doi.org\/10.1016\/j.febslet.2013.05.059 (2013).","journal-title":"FEBS Lett."},{"issue":"6","key":"36485_CR17","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1007\/s13277-014-1688-4","volume":"35","author":"X Gu","year":"2014","unstructured":"Gu, X. et al. Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro. Tumour Biol. 35(6), 5287\u20135293. https:\/\/doi.org\/10.1007\/s13277-014-1688-4 (2014).","journal-title":"Tumour Biol."},{"key":"36485_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.omtn.2019.04.017","volume":"16","author":"F-Q Dai","year":"2019","unstructured":"Dai, F.-Q. et al. miR-150-5p inhibits non-small-cell lung cancer metastasis and recurrence by targeting HMGA2 and \u03b2-catenin signaling. Mol. Ther. Nucleic Acids 16, 675\u2013685. https:\/\/doi.org\/10.1016\/j.omtn.2019.04.017 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"36485_CR19","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.5808\/GI.2020.18.4.e36","volume":"18","author":"D Seo","year":"2020","unstructured":"Seo, D., Kim, D., Chae, Y. & Kim, W. The ceRNA network of lncRNA and miRNA in lung cancer. Genomics Inform. 18(4), e36. https:\/\/doi.org\/10.5808\/GI.2020.18.4.e36 (2020).","journal-title":"Genomics Inform."},{"key":"36485_CR20","doi-asserted-by":"publisher","first-page":"758591","DOI":"10.3389\/fgene.2021.758591","volume":"12","author":"T Wang","year":"2021","unstructured":"Wang, T. et al. Identification of lncRNA\u2013miRNA\u2013mRNA networks linked to non-small lung cancer resistance to inhibitors of epidermal growth factor receptor. Front. Genet. 12, 758591. https:\/\/doi.org\/10.3389\/fgene.2021.758591 (2021).","journal-title":"Front. Genet."},{"issue":"2","key":"36485_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.7150\/ijms.49730","volume":"18","author":"T-T Liu","year":"2021","unstructured":"Liu, T.-T. et al. LncRNA XIST acts as a MicroRNA-520 sponge to regulate the Cisplatin resistance in NSCLC cells by mediating BAX through CeRNA network. Int. J. Med. Sci. 18(2), 419\u2013431. https:\/\/doi.org\/10.7150\/ijms.49730 (2021).","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"36485_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-017-0685-9","volume":"16","author":"W Lu","year":"2017","unstructured":"Lu, W. et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol. Cancer 16(1), 118. https:\/\/doi.org\/10.1186\/s12943-017-0685-9 (2017).","journal-title":"Mol. Cancer"},{"issue":"9","key":"36485_CR23","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/j.celrep.2016.04.018","volume":"15","author":"K Schmidt","year":"2016","unstructured":"Schmidt, K. et al. The lncRNA SLNCR1 mediates melanoma invasion through a conserved SRA1-like region. Cell Rep. 15(9), 2025\u20132037. https:\/\/doi.org\/10.1016\/j.celrep.2016.04.018 (2016).","journal-title":"Cell Rep."},{"issue":"12","key":"36485_CR24","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1080\/15476286.2018.1553481","volume":"15","author":"A Roth","year":"2018","unstructured":"Roth, A. et al. Targeting LINC00673 expression triggers cellular senescence in lung cancer. RNA Biol. 15(12), 1499\u20131511. https:\/\/doi.org\/10.1080\/15476286.2018.1553481 (2018).","journal-title":"RNA Biol."},{"issue":"18","key":"36485_CR25","doi-asserted-by":"publisher","first-page":"25558","DOI":"10.18632\/oncotarget.8338","volume":"7","author":"X Shi","year":"2016","unstructured":"Shi, X. et al. Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer. Oncotarget 7(18), 25558\u201325575. https:\/\/doi.org\/10.18632\/oncotarget.8338 (2016).","journal-title":"Oncotarget"},{"key":"36485_CR26","unstructured":"\u2018Definition of pack year - NCI Dictionary of Cancer Terms - National Cancer Institute\u2019, Feb. 02, 2011. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/pack-year (Accessed 26 January 2022)."},{"issue":"5","key":"36485_CR27","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1007\/s11033-019-04993-3","volume":"46","author":"K Baran","year":"2019","unstructured":"Baran, K. et al. An assessment of the relationship between the expression of CCR7\/CCL19 axis and selected regulatory miRNAs in non-small cell lung cancer. Mol. Biol. Rep. 46(5), 5389\u20135396. https:\/\/doi.org\/10.1007\/s11033-019-04993-3 (2019).","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"36485_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4329\/wjr.v4.i4.128","volume":"4","author":"S Mirsadraee","year":"2012","unstructured":"Mirsadraee, S., Oswal, D., Alizadeh, Y., Caulo, A. & van Beek, E. J. The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J. Radiol. 4(4), 128\u2013134. https:\/\/doi.org\/10.4329\/wjr.v4.i4.128 (2012).","journal-title":"World J. Radiol."},{"key":"36485_CR29","unstructured":"\u2018Lung Cancer - Non-Small Cell - Statistics\u2019, Cancer.Net, Jun. 25, 2012. https:\/\/www.cancer.net\/cancer-types\/lung-cancer-non-small-cell\/statistics (Accessed 04 December 2022)."},{"issue":"10","key":"36485_CR30","doi-asserted-by":"publisher","first-page":"938","DOI":"10.7150\/jca.12286","volume":"6","author":"S Rivas-Fuentes","year":"2015","unstructured":"Rivas-Fuentes, S. et al. Role of chemokines in non-small cell lung cancer: angiogenesis and inflammation. J. Cancer 6(10), 938\u2013952. https:\/\/doi.org\/10.7150\/jca.12286 (2015).","journal-title":"J. Cancer"},{"key":"36485_CR31","doi-asserted-by":"publisher","first-page":"5563746","DOI":"10.1155\/2021\/5563746","volume":"2021","author":"S Ramachandran","year":"2021","unstructured":"Ramachandran, S. et al. Role of cytokines and chemokines in NSCLC immune navigation and proliferation. Oxid. Med. Cell Longev. 2021, 5563746. https:\/\/doi.org\/10.1155\/2021\/5563746 (2021).","journal-title":"Oxid. Med. Cell Longev."},{"issue":"16","key":"36485_CR32","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","volume":"285","author":"CE Hughes","year":"2018","unstructured":"Hughes, C. E. & Nibbs, R. J. B. A guide to chemokines and their receptors. FEBS J. 285(16), 2944\u20132971. https:\/\/doi.org\/10.1111\/febs.14466 (2018).","journal-title":"FEBS J."},{"issue":"6","key":"36485_CR33","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.3892\/ol.2017.7253","volume":"14","author":"X-P Zhang","year":"2017","unstructured":"Zhang, X.-P. et al. Role of CCL20\/CCR6 and the ERK signaling pathway in lung adenocarcinoma. Oncol. Lett. 14(6), 8183\u20138189. https:\/\/doi.org\/10.3892\/ol.2017.7253 (2017).","journal-title":"Oncol. Lett."},{"issue":"11","key":"36485_CR34","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.7150\/ijbs.73275","volume":"18","author":"T Fan","year":"2022","unstructured":"Fan, T. et al. CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition. Int. J. Biol. Sci. 18(11), 4275\u20134288. https:\/\/doi.org\/10.7150\/ijbs.73275 (2022).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"36485_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/jcm11030655","volume":"11","author":"K Baran","year":"2022","unstructured":"Baran, K., Kordiak, J., Jab\u0142o\u0144ski, S., Antczak, A. & Brzezia\u0144ska-Lasota, E. The significance of the alter miR let-7a and miR-335 expression level regulating the CCR7\/CCL19 axis as potential biomarkers of tumor progression in NSCLC. J. Clin. Med. 11(3), 655. https:\/\/doi.org\/10.3390\/jcm11030655 (2022).","journal-title":"J. Clin. Med."},{"issue":"2","key":"36485_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ijc.11063","volume":"105","author":"I Takanami","year":"2003","unstructured":"Takanami, I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: Correlation with lymph node metastasis. Int. J. Cancer 105(2), 186\u2013189. https:\/\/doi.org\/10.1002\/ijc.11063 (2003).","journal-title":"Int. J. Cancer"},{"issue":"5","key":"36485_CR37","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1158\/0008-5472.can-03-2968","volume":"64","author":"J Wang","year":"2004","unstructured":"Wang, J. et al. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res. 64(5), 1861\u20131866. https:\/\/doi.org\/10.1158\/0008-5472.can-03-2968 (2004).","journal-title":"Cancer Res."},{"issue":"1","key":"36485_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s13277-010-0113-x","volume":"32","author":"Y Minamiya","year":"2011","unstructured":"Minamiya, Y. et al. Expression of the chemokine receptor CCR6 correlates with a favorable prognosis in patients with adenocarcinoma of the lung. Tumour Biol. 32(1), 197\u2013202. https:\/\/doi.org\/10.1007\/s13277-010-0113-x (2011).","journal-title":"Tumour Biol."},{"issue":"10","key":"36485_CR39","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/sj.cgt.7701074","volume":"14","author":"A Sutherland","year":"2007","unstructured":"Sutherland, A., Mirjolet, J.-F., Maho, A. & Parmentier, M. Expression of the chemokine receptor CCR6 in the Lewis lung carcinoma (LLC) cell line reduces its metastatic potential in vivo. Cancer Gene Ther. 14(10), 847\u2013857. https:\/\/doi.org\/10.1038\/sj.cgt.7701074 (2007).","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"36485_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3816\/CLC.2010.n.024","volume":"11","author":"CM Raynaud","year":"2010","unstructured":"Raynaud, C. M. et al. Expression of chemokine receptor CCR6 as a molecular determinant of adrenal metastatic relapse in patients with primary lung cancer. Clin. Lung Cancer 11(3), 187\u2013191. https:\/\/doi.org\/10.3816\/CLC.2010.n.024 (2010).","journal-title":"Clin. Lung Cancer"},{"issue":"2","key":"36485_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1183\/09031936.00209513","volume":"44","author":"GJ Zijlstra","year":"2014","unstructured":"Zijlstra, G. J. et al. Glucocorticoids induce the production of the chemoattractant CCL20 in airway epithelium. Eur. Respir. J. 44(2), 361\u2013370. https:\/\/doi.org\/10.1183\/09031936.00209513 (2014).","journal-title":"Eur. Respir. J."},{"issue":"3","key":"36485_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1365-2567.2003.01655.x","volume":"109","author":"M Nouri-Shirazi","year":"2003","unstructured":"Nouri-Shirazi, M. & Guinet, E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 109(3), 365\u2013373. https:\/\/doi.org\/10.1046\/j.1365-2567.2003.01655.x (2003).","journal-title":"Immunology"},{"issue":"5","key":"36485_CR43","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nri803","volume":"2","author":"M Sopori","year":"2002","unstructured":"Sopori, M. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2(5), 372\u2013377. https:\/\/doi.org\/10.1038\/nri803 (2002).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"36485_CR44","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/cei.13388","volume":"199","author":"CE Valdez-Miramontes","year":"2020","unstructured":"Valdez-Miramontes, C. E. et al. Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis. Clin. Exp. Immunol. 199(2), 230\u2013243. https:\/\/doi.org\/10.1111\/cei.13388 (2020).","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"36485_CR45","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/glia.22307","volume":"60","author":"GP Meares","year":"2012","unstructured":"Meares, G. P., Ma, X., Qin, H. & Benveniste, E. N. Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 60(5), 771\u2013781. https:\/\/doi.org\/10.1002\/glia.22307 (2012).","journal-title":"Glia"},{"key":"36485_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.biopha.2014.12.008","volume":"69","author":"C Zhang","year":"2015","unstructured":"Zhang, C. et al. The role of CCL20\/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients. Biomed. Pharmacother. 69, 242\u2013248. https:\/\/doi.org\/10.1016\/j.biopha.2014.12.008 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"36485_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41416-020-0943-2","volume":"123","author":"A Hippe","year":"2020","unstructured":"Hippe, A. et al. EGFR\/Ras-induced CCL20 production modulates the tumour microenvironment. Br. J. Cancer 123, 1\u201313. https:\/\/doi.org\/10.1038\/s41416-020-0943-2 (2020).","journal-title":"Br. J. Cancer"},{"key":"36485_CR48","doi-asserted-by":"publisher","first-page":"807497","DOI":"10.3389\/fmolb.2022.807497","volume":"9","author":"P Zheng","year":"2022","unstructured":"Zheng, P. et al. Establishment of a prognostic model of lung adenocarcinoma based on tumor heterogeneity. Front. Mol. Biosci. 9, 807497. https:\/\/doi.org\/10.3389\/fmolb.2022.807497 (2022).","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"36485_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jjco\/hyr188","volume":"42","author":"A Kawase","year":"2012","unstructured":"Kawase, A. et al. Differences between squamous cell carcinoma and adenocarcinoma of the lung: Are adenocarcinoma and squamous cell carcinoma prognostically equal?. Jpn. J. Clin. Oncol. 42(3), 189\u2013195. https:\/\/doi.org\/10.1093\/jjco\/hyr188 (2012).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"6","key":"36485_CR50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1159\/000499337","volume":"63","author":"G Poulet","year":"2019","unstructured":"Poulet, G., Massias, J. & Taly, V. Liquid biopsy: General concepts. ACY 63(6), 449\u2013455. https:\/\/doi.org\/10.1159\/000499337 (2019).","journal-title":"ACY"},{"key":"36485_CR51","doi-asserted-by":"publisher","unstructured":"T. Hirahata, R. ul Quraish, A. ul Quraish, S. ul Quraish, M. Naz, and M. A. Razzaq, Liquid biopsy: A distinctive approach to the diagnosis and prognosis of cancer. Cancer Inform, vol. 21, p. 11769351221076062, 2022, doi: https:\/\/doi.org\/10.1177\/11769351221076062.","DOI":"10.1177\/11769351221076062"},{"issue":"3","key":"36485_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jmoldx.2015.02.001","volume":"17","author":"B Gold","year":"2015","unstructured":"Gold, B., Cankovic, M., Furtado, L. V., Meier, F. & Gocke, C. D. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility?. J. Mol. Diagn. 17(3), 209\u2013224. https:\/\/doi.org\/10.1016\/j.jmoldx.2015.02.001 (2015).","journal-title":"J. Mol. Diagn."},{"key":"36485_CR53","doi-asserted-by":"publisher","first-page":"643942","DOI":"10.3389\/fcell.2021.643942","volume":"9","author":"X Zhu","year":"2021","unstructured":"Zhu, X. et al. Frontiers of MicroRNA signature in non-small cell lung cancer. Front. Cell Dev. Biol. 9, 643942. https:\/\/doi.org\/10.3389\/fcell.2021.643942 (2021).","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"36485_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/genes13071174","volume":"13","author":"Z Shafat","year":"2022","unstructured":"Shafat, Z. et al. Identification of the key miRNAs and genes associated with the regulation of non-small cell lung cancer: A network-based approach. Genes 13(7), 7. https:\/\/doi.org\/10.3390\/genes13071174 (2022).","journal-title":"Genes"},{"issue":"7","key":"36485_CR55","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/ijms20071611","volume":"20","author":"K-L Wu","year":"2019","unstructured":"Wu, K.-L., Tsai, Y.-M., Lien, C.-T., Kuo, P.-L. & Hung, J.-Y. The roles of MicroRNA in lung cancer. Int. J. Mol. Sci. 20(7), 1611. https:\/\/doi.org\/10.3390\/ijms20071611 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"36485_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2018.07.003","volume":"70","author":"MA Iqbal","year":"2019","unstructured":"Iqbal, M. A., Arora, S., Prakasam, G., Calin, G. A. & Syed, M. A. MicroRNA in lung cancer: Role, mechanisms, pathways and therapeutic relevance. Mol. Aspects Med. 70, 3\u201320. https:\/\/doi.org\/10.1016\/j.mam.2018.07.003 (2019).","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"36485_CR57","doi-asserted-by":"publisher","first-page":"e0264645","DOI":"10.1371\/journal.pone.0264645","volume":"17","author":"H Liu","year":"2022","unstructured":"Liu, H., Li, T., Dong, C. & Lyu, J. Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma. PLOS ONE 17(3), e0264645. https:\/\/doi.org\/10.1371\/journal.pone.0264645 (2022).","journal-title":"PLOS ONE"},{"issue":"1","key":"36485_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3892\/ol.2015.3170","volume":"10","author":"F Wang","year":"2015","unstructured":"Wang, F., Ren, X. & Zhang, X. Role of microRNA-150 in solid tumors. Oncol. Lett. 10(1), 11\u201316. https:\/\/doi.org\/10.3892\/ol.2015.3170 (2015).","journal-title":"Oncol. Lett."},{"issue":"1","key":"36485_CR59","first-page":"842","volume":"8","author":"Q-W Yin","year":"2015","unstructured":"Yin, Q.-W. et al. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 8(1), 842\u2013846 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"36485_CR60","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3892\/or.2012.2152","volume":"29","author":"Y Sun","year":"2013","unstructured":"Sun, Y. et al. Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features. Oncol. Rep. 29(2), 704\u2013712. https:\/\/doi.org\/10.3892\/or.2012.2152 (2013).","journal-title":"Oncol. Rep."},{"key":"36485_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgac059","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Low expression of exosomal miR-150 predicts poor prognosis in colorectal cancer patients after surgical resections. Carcinogenesis https:\/\/doi.org\/10.1093\/carcin\/bgac059 (2022).","journal-title":"Carcinogenesis"},{"issue":"5","key":"36485_CR62","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/cancers11050601","volume":"11","author":"S Misono","year":"2019","unstructured":"Misono, S. et al. Molecular pathogenesis of gene regulation by the miR-150 duplex: miR-150-3p regulates TNS4 in lung adenocarcinoma. Cancers (Basel) 11(5), 601. https:\/\/doi.org\/10.3390\/cancers11050601 (2019).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"36485_CR63","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3892\/ijo.2017.4232","volume":"52","author":"T Suetsugu","year":"2018","unstructured":"Suetsugu, T. et al. Downregulation of matrix metalloproteinase 14 by the antitumor miRNA, miR-150-5p, inhibits the aggressiveness of lung squamous cell carcinoma cells. Int. J. Oncol. 52(3), 913\u2013924. https:\/\/doi.org\/10.3892\/ijo.2017.4232 (2018).","journal-title":"Int. J. Oncol."},{"key":"36485_CR64","doi-asserted-by":"publisher","first-page":"5917506","DOI":"10.1155\/2021\/5917506","volume":"2021","author":"C Zheng","year":"2021","unstructured":"Zheng, C. et al. Comprehensive analysis of the immune and prognostic implication of MMP14 in lung cancer. Dis. Markers 2021, 5917506. https:\/\/doi.org\/10.1155\/2021\/5917506 (2021).","journal-title":"Dis. Markers"},{"issue":"9","key":"36485_CR65","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1177\/0960327117741749","volume":"37","author":"H Xue","year":"2018","unstructured":"Xue, H. & Li, M. MicroRNA-150 protects against cigarette smoke-induced lung inflammation and airway epithelial cell apoptosis through repressing p53: MicroRNA-150 in CS-induced lung inflammation. Hum. Exp. Toxicol. 37(9), 920\u2013928. https:\/\/doi.org\/10.1177\/0960327117741749 (2018).","journal-title":"Hum. Exp. Toxicol."},{"key":"36485_CR66","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.toxlet.2019.11.024","volume":"320","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Benzo(a)pyrene regulated A549 cell migration, invasion and epithelial-mesenchymal transition by up-regulating long non-coding RNA linc00673. Toxicol. Lett. 320, 37\u201345. https:\/\/doi.org\/10.1016\/j.toxlet.2019.11.024 (2020).","journal-title":"Toxicol. Lett."},{"key":"36485_CR67","unstructured":"\"Measures of Diagnostic Accuracy: Basic Definitions - PMC\u201d. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4975285\/ (Accessed 24 April 2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36485-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T12:12:43Z","timestamp":1686744763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36485-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36485"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36485-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"24 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9642"}}